NLRP3-IN-11 structure
|
Common Name | NLRP3-IN-11 | ||
---|---|---|---|---|
CAS Number | 2769040-91-5 | Molecular Weight | 344.80 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C17H17ClN4O2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of NLRP3-IN-11NLRP3-IN-11 is a NLR family pyrin domain containing 3 (NLRP3) proteins inhibitor. NLRP3-IN-11 has biological activity for NLRP3 with an IC50 value of <0.3 μM. NLRP3-IN-11 can be used for the researh of inflammatory and degenerative diseases including NASH, atherosclerosis and other cardiovascular diseases, Alzheimer's disease, Parkinson's disease, diabetes, gout, and numerous other autoinflammatory diseases[1]. |
Name | NLRP3-IN-11 |
---|
Description | NLRP3-IN-11 is a NLR family pyrin domain containing 3 (NLRP3) proteins inhibitor. NLRP3-IN-11 has biological activity for NLRP3 with an IC50 value of <0.3 μM. NLRP3-IN-11 can be used for the researh of inflammatory and degenerative diseases including NASH, atherosclerosis and other cardiovascular diseases, Alzheimer's disease, Parkinson's disease, diabetes, gout, and numerous other autoinflammatory diseases[1]. |
---|---|
Related Catalog | |
Target |
NLRP3:<0.3 μM (IC50) |
In Vitro | NLRP3-IN-11 has biological activity with an IC50 value of <0.3 μM in human PBMC NLRP3 assay[1] |
References |
[1]. HY-W048205, et al. Compounds for inhibiting NLRP3 and uses thereof. Patent. US11319319B1. |
Molecular Formula | C17H17ClN4O2 |
---|---|
Molecular Weight | 344.80 |